Expression of plant-produced anti-PD-L1 antibody with anoikis sensitizing activity in human lung cancer cells via., suppression on epithelial-mesenchymal transition

Immune checkpoint antibodies in cancer treatment are receptor-ligand pairs that modulate cancer immunity. PD-1/PD-L1 pathway has emerged as one of the major targets in cancer immunotherapy. Atezolizumab, the first anti-PD-L1 antibody approved for the treatment of metastatic urothelial, non-small cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Phetphoung, Thareeya, Malla, Ashwini, Rattanapisit, Kaewta, Pisuttinusart, Nuttapat, Damrongyot, Naruechai, Joyjamras, Keerati, Chanvorachote, Pithi, Phakham, Tanapati, Wongtangprasert, Tossapon, Strasser, Richard, Chaotham, Chatchai, Phoolcharoen, Waranyoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651560/
https://www.ncbi.nlm.nih.gov/pubmed/36367857
http://dx.doi.org/10.1371/journal.pone.0274737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9651560/
https://www.ncbi.nlm.nih.gov/pubmed/36367857
http://dx.doi.org/10.1371/journal.pone.0274737

Ejemplares similares